NLM Logo

tisagenlecleucel MeSH Supplementary Concept Data 2025


MeSH Supplementary
tisagenlecleucel
Unique ID
C000626284
RDF Unique Identifier
http://id.nlm.nih.gov/mesh/C000626284
Entry Term(s)
CTL019
KYMRIAH
Pharm Action
Antineoplastic Agents, Immunological
Registry Numbers
Q6C9WHR03O
Heading Mapped to
*Receptors, Antigen, T-Cell
Frequency
200
Note
anti-CD19 chimeric antigen receptor (CAR) T-cell therapy for treatment of B-Cell lymphoblastic leukemia
Source
N Engl J Med. 2018 Feb 1;378(5)439-448
Date of Entry
2018/02/21
Revision Date
2021/11/05
tisagenlecleucel Preferred
CTL019 Broader
KYMRIAH Related
page delivered in 0.003s